Since 2023, ONO has been participating in Access Accelerated, a global pa...
In order to realize a resource recycling society, we have been working...
We have been holding ESG presentation Meeting every year since March 2...
Dissemination of Medical Information Participating in Relay for Life...
Since FY2014, ONO has been a constant supporting member of a public i...
Traveling Science Workshop "Kusuri no Himitsu Manabu" Efforts for Ca...
At Ono Pharmaceutical, the Board of Directors oversees important manageme...
Please refer to the “Corporate Governance Report” below for details on ou...
Our efforts to promote diversity focus on three main areas: management*, ...
Our Position on Biodiversity Initiatives to Reduce Negative Impacts ...
There are still countries and regions in the world where the healthcare i...
We disclose financial results and other timely disclosure information ...
The total volume of our industrial waste in FY2024 was 818.6 tons, a 248....
We aim for highly transparent management, recognize the importance of ...
Contribution by ONO to the SDGs We contribute to Goal 3, Goal ...
For more than 300 years since our foundation, we have walked hand...
Following the revision of the Curriculum Guidelines by the Ministry of ...
Our Stance on Sustainable Procurement Joining the PSCI (Pharmaceutical...
We pay wages to our employees in compliance with the Labor Standards Act ...
Risk Management Business Continuity Plan (BCP) Major Risks Infor...
Based on our medium- to long-term environmental vision, ECO VISION 2050, ...
We have established a Sales Information Activities Supervisory Division w...
